CSIMarket
 
Syndax Pharmaceuticals Inc   (SNDX)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 
Price: $18.0600 $0.27 1.518%
Day's High: $18.48 Week Perf: -7.72 %
Day's Low: $ 17.84 30 Day Perf: 2.09 %
Volume (M): 423 52 Wk High: $ 27.85
Volume (M$): $ 7,645 52 Wk Avg: $19.15
Open: $17.96 52 Wk Low: $13.02



 Market Capitalization (Millions $) 930
 Shares Outstanding (Millions) 52
 Employees -
 Revenues (TTM) (Millions $) 2
 Net Income (TTM) (Millions $) -86
 Cash Flow (TTM) (Millions $) 20
 Capital Exp. (TTM) (Millions $) 0

Syndax Pharmaceuticals Inc


   Company Address: 35 Gatehouse Drive Waltham 2451 MA
   Company Phone Number: 419-1400   Stock Exchange / Ticker: NASDAQ SNDX
   SNDX is expected to report next financial results on March 10, 2022.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



United States Basketball League Inc

Sales and Earnings Unchanged

In the third quarter of 2020 United States Basketball League Inc reached break-even of $0.00 per share compared to $-0.01 a year ago and from $0.00 per share from the previous quarter.

United States Basketball League Inc reported operating deficit of $-0.004843 millions, in the third quarter of 2020, an improvement from the operating loss of $-0.008242 millions, realized in third quarter of 2019

Tandy Leather Factory Inc

Tandy Leather Factory Inc announced financial fourth quarter of 2019 operating deficit of $-6.064562 millions

In the financial fourth quarter of 2019 Tandy Leather Factory Inc increased losses of $-0.48 per share compared to $-0.07 a year ago and increased losses from $-0.19 per share from the previous quarter.

Sales faded by -35.06% to $16.07 millions from $24.74 millions in the same quarter a year ago and sequentially Sales decreased by -1.49% from $16.31 millions.
Tandy Leather Factory Inc reported net loss of $-1.90 millions and Sales of $74.92 millions for the fiscal year 2019.

Company recorded loss per share of $-0.21 compared to $0.21 in the previous fiscal year, while Sales deteriorated by -9.84 % from $83.10 millions a year ago.

Acasti Pharma Inc

Acasti Pharma Inc announced financial time frame ending Mar 31 2021 operating loss of $-2.3 millions

In the financial time frame ending Mar 31 2021 Acasti Pharma Inc loss increased of $-0.03 per share compared to $0.00 a year ago and from $-0.03 per share from the previous quarter.

Sales remained unchanged to $0.12 millions from $0.00 millions in the same quarter a year ago and sequentially Sales surged by 41.98 % from $0.08 millions.
Acasti Pharma Inc reported net loss of $-19.68 millions and Sales of $0.20 millions for the fiscal year 2021.

Company has decreased loss per share to $-0.17 from $-0.30 in the previous fiscal year, while by 0 % from $0.00 millions a year ago.

Sony Group Corporation

Impressive Income Growth, Single Digit Topline Growth

In the fourth quarter of 2021 Sony Group Corporation income surged by 96.75 % of $8.47 per share compared to $4.30 a year ago and from $0.00 per share from the previous quarter.

Sales grew by 5.53% to $81.32 billions from $77.06 billions in the same quarter a year ago and sequentially from $0.00 millions.
In the fiscal year 2021, Sony Group Corporation reported Sales of $81.32 billions and net income of $10.77 billions.

Eps soared by 96.75 % to $8.47 per share from $4.30 in the previous fiscal year, while Sales increased by 5.53 % from $77.06 billions a year ago.

Alberton Acquisition Corporation

Alberton Acquisition Corporation announced first quarter of 2020 earnings season operating deficit of $-0.22622 millions

In the first quarter of 2020 earnings season Alberton Acquisition Corporation increased losses of $-0.04 per share compared to $-0.02 a year ago and eps fell from $0.06 per share from the previous quarter.

Alberton Acquisition Corporation reported operating loss of $-0.22622 millions, in the first quarter of 2020 earnings season, a deterioration from the operating shortfall of $-0.149055 millions, realized in first quarter of 2019






 

Syndax Pharmaceuticals Inc 's Segments
 
 
• View Complete Report


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

MTSL's Profile

Stock Price

MTSL's Financials

Business Description

Fundamentals

Charts & Quotes

MTSL's News

Suppliers

MTSL's Competitors

Customers & Markets

Economic Indicators

MTSL's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071